Rosiglitazone increases fatty acid oxidation and fatty acid translocase (FAT/CD36) but not carnitine palmitoyltransferase I in rat muscle mitochondria.
about
Bioanalysis of eukaryotic organellesAMP-activated protein kinase is required for exercise-induced peroxisome proliferator-activated receptor co-activator 1 translocation to subsarcolemmal mitochondria in skeletal muscleDPDR-CPI, a server that predicts Drug Positioning and Drug Repositioning via Chemical-Protein InteractomeCompensatory increases in nuclear PGC1alpha protein are primarily associated with subsarcolemmal mitochondrial adaptations in ZDF ratsCellular fatty acid uptake: a pathway under construction.Regulation of fatty acid oxidation in mouse cumulus-oocyte complexes during maturation and modulation by PPAR agonists.FAT/CD36 is localized in sarcolemma and in vesicle-like structures in subsarcolemma regions but not in mitochondriaRosiglitazone causes cardiotoxicity via peroxisome proliferator-activated receptor γ-independent mitochondrial oxidative stress in mouse heartsEndogenous peroxisome proliferator-activated receptor-gamma augments fatty acid uptake in oxidative muscle.Greater transport efficiencies of the membrane fatty acid transporters FAT/CD36 and FATP4 compared with FABPpm and FATP1 and differential effects on fatty acid esterification and oxidation in rat skeletal muscleIdentification of a novel malonyl-CoA IC(50) for CPT-I: implications for predicting in vivo fatty acid oxidation rates.CD36: a multi-modal target for acute stroke therapy.Studies of Secondary Melanoma on C57BL/6J Mouse Liver Using 1H NMR MetabolomicsIn vivo multi-tissue efficacy of peroxisome proliferator-activated receptor-γ therapy on glucose and fatty acid metabolism in obese type 2 diabetic rats.In vivo metabolic phenotyping of myocardial substrate metabolism in rodents: differential efficacy of metformin and rosiglitazone monotherapy.Fatty acid incubation of myotubes from humans with type 2 diabetes leads to enhanced release of beta-oxidation products because of impaired fatty acid oxidation: effects of tetradecylthioacetic acid and eicosapentaenoic acid.Restoring AS160 phosphorylation rescues skeletal muscle insulin resistance and fatty acid oxidation while not reducing intramuscular lipids.A decreased n-6/n-3 ratio in the fat-1 mouse is associated with improved glucose tolerance.Thujone, a component of medicinal herbs, rescues palmitate-induced insulin resistance in skeletal muscle.Endocrine control of oleic acid and glucose metabolism in rainbow trout (Oncorhynchus mykiss) muscle cells in culture.Subcellular lipid droplet distribution in red and white muscles in the obese Zucker rat.A grape polyphenol extract modulates muscle membrane fatty acid composition and lipid metabolism in high-fat--high-sucrose diet-fed rats.
P2860
Q28384122-9E374474-5FDE-4BA9-8123-7257BE8E328BQ28582895-004380F7-4AC7-4A81-B32B-1BA1C0CB80DCQ28822352-99A097DB-97DF-4A84-B220-9DA4D0134BAAQ33526750-8E9221BB-922E-4BE4-9F20-DE5D6A353870Q33753883-6F2497A8-A39A-45D2-866F-760E7273F53EQ34403000-C6C5E9E1-E611-455C-BEC3-879EFD5B8353Q34559958-4769AC4C-518F-4151-918D-56310AA4659AQ34569388-82211BD7-C9FB-4390-9F51-7B87092D4ACBQ36976374-9289A4A5-B07B-4FD0-BC8F-CA08B904B05DQ37269130-B7196254-B7E1-4279-A46E-A91C2286D3BBQ37393399-1B0F4B96-2135-4E0B-8918-9BF9D077272AQ37459051-A1C6B6C7-B134-45AF-9269-0124291F89C4Q37608810-DECED31D-E853-48B5-9D5A-0D86642DC9A2Q41534968-5E12CC48-6440-418F-99A5-3A9FDBC15571Q41832683-667FB476-904E-42ED-A6A4-D2B18DEB9D77Q41982943-F91FCF23-A8DF-4007-8DB8-B0B2F8DC7E34Q42459278-1AA36715-DDCA-4075-A5CD-7218A3B5FC45Q42852208-4979C986-D447-4DFD-8050-279FB6F8EA62Q43007275-347AD544-837A-440D-82CF-6655F5DC8134Q43059423-9B2A4909-8F25-46FC-98D2-EBEB44A921C5Q50522313-866C7D58-B5AF-41E6-9F5F-BD204C29E892Q50537339-7336AB3E-FE68-4EFA-B3C5-669018E39271
P2860
Rosiglitazone increases fatty acid oxidation and fatty acid translocase (FAT/CD36) but not carnitine palmitoyltransferase I in rat muscle mitochondria.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Rosiglitazone increases fatty ...... I in rat muscle mitochondria.
@en
Rosiglitazone increases fatty acid oxidation and fatty acid translocase
@nl
type
label
Rosiglitazone increases fatty ...... I in rat muscle mitochondria.
@en
Rosiglitazone increases fatty acid oxidation and fatty acid translocase
@nl
prefLabel
Rosiglitazone increases fatty ...... I in rat muscle mitochondria.
@en
Rosiglitazone increases fatty acid oxidation and fatty acid translocase
@nl
P2093
P2860
P1476
Rosiglitazone increases fatty ...... I in rat muscle mitochondria.
@en
P2093
Arend Bonen
Carley R Benton
Graham P Holloway
Jan F C Glatz
Joost J J F P Luiken
Lawrence L Spriet
Narendra N Tandon
S E Campbell
Yuko Yoshida
P2860
P304
P356
10.1113/JPHYSIOL.2007.146563
P407
P577
2008-01-31T00:00:00Z